FTCM
TERN

First Trust Capital Management’s Terns Pharmaceuticals TERN Stock Holding History

First Trust Capital Management’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-904,161
Closed -$47.7M – 188
2026
Q1 		$47.7M Buy
+904,161
New +$37.1M 2.5% 10

Other funds holding TERN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

First Trust Capital Management's TERN Position: Q2 2026 in Review

First Trust Capital Management sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 904,161 shares — an estimated $47.7M sold.

First Trust Capital Management first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $47.7M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • First Trust Capital Management reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • First Trust Capital Management sold 904,161 Terns Pharmaceuticals shares in Q2 2026, an estimated $47.7M.
  • First Trust Capital Management first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • First Trust Capital Management's Terns Pharmaceuticals position peaked at $47.7M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on First Trust Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.